These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7675950)

  • 21. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
    Priestley T; Marshall GR; Hill RG; Kemp JA
    Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Agonist-like character of the (R)-enantiomer of 1-hydroxy-3-amino-pyrrolid-2-one (HA-966).
    Pullan LM; Verticelli AM; Paschetto KA
    Eur J Pharmacol; 1991 Sep; 208(1):25-9. PubMed ID: 1834473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A partial agonist model used in the allosteric modulation of the NMDA receptor.
    Robichon R; Randall PK; Leslie SW
    Eur J Pharmacol; 1997 Jun; 328(2-3):255-63. PubMed ID: 9218709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NMDA receptors with different sensitivities to magnesium and ifenprodil control the release of [14C]acetylcholine and [3H]spermidine from rat striatal slices in vitro.
    Nicolas C; Fage D; Carter C
    J Neurochem; 1994 May; 62(5):1835-9. PubMed ID: 7908945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Striatal NTS1 , dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat.
    Ferraro L; O'Connor WT; Beggiato S; Tomasini MC; Fuxe K; Tanganelli S; Antonelli T
    Eur J Neurosci; 2012 Jan; 35(2):207-20. PubMed ID: 22211865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GlycineB antagonists and partial agonists in rodent models of Parkinson's disease--comparison with uncompetitive N-methyl-D-aspartate receptor antagonist.
    Karcz-Kubicha M; Lorenz B; Danysz W
    Neuropharmacology; 1999 Jan; 38(1):109-19. PubMed ID: 10193902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacology of native N-methyl-D-aspartate receptor subtypes: different receptors control the release of different striatal and spinal transmitters.
    Nankai M; Klarica M; Fage D; Carter C
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jan; 22(1):35-64. PubMed ID: 9533166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in surface expression of N-methyl-D-aspartate receptors in the striatum in a rat model of Parkinson's disease.
    Gan J; Qi C; Mao LM; Liu Z
    Drug Des Devel Ther; 2014; 8():165-73. PubMed ID: 24465126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of [3H]3-((+-)-2-carboxypiperazin-4-yl)propyl-1-phosphonic acid ([3H]CPP) binding by ligands acting at the glycine and the polyamine sites of the rat brain NMDA receptor complex.
    Porter RH; Briggs RS; Roberts PJ
    Eur J Pharmacol; 1992 Sep; 227(1):83-8. PubMed ID: 1426025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of a partial agonist and a full antagonist acting at the glycine site of the NMDA receptor on inflammation-induced mechanical hyperalgesia in rats.
    Laird JM; Mason GS; Webb J; Hill RG; Hargreaves RJ
    Br J Pharmacol; 1996 Apr; 117(7):1487-92. PubMed ID: 8730744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor.
    Witkin JM; Brave S; French D; Geter-Douglass B
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1267-73. PubMed ID: 8531091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological properties of the N-methyl-D-aspartate receptor system coupled to the evoked release of gamma-[3H] aminobutyric acid from striatal neurons in primary culture.
    Weiss S
    J Pharmacol Exp Ther; 1990 Jan; 252(1):380-6. PubMed ID: 1967648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
    Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T
    Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional interactions between glutamate and dopamine in the rat striatum.
    Amalric M; Ouagazzal A; Baunez C; Nieoullon A
    Neurochem Int; 1994 Aug; 25(2):123-31. PubMed ID: 7994193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low doses of the glycine/NMDA receptor antagonist R-(+)-HA-966 but not D-cycloserine induce paroxysmal activity in limbic brain regions of kindled rats.
    Wlaź P; Ebert U; Löscher W
    Eur J Neurosci; 1994 Nov; 6(11):1710-9. PubMed ID: 7874310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On central muscle relaxants, strychnine-insensitive glycine receptors and two old drugs: zoxazolamine and HA-966.
    McMillen BA; Williams HL; Lehmann H; Shepard PD
    J Neural Transm Gen Sect; 1992; 89(1-2):11-25. PubMed ID: 1329854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biphenyl-derivatives of 2-amino-7-phosphonoheptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonist--I. Pharmacological characterization in vitro.
    Urwyler S; Laurie D; Lowe DA; Meier CL; Müller W
    Neuropharmacology; 1996 Jun; 35(6):643-54. PubMed ID: 8887974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The anticonvulsant and behavioural profile of L-687,414, a partial agonist acting at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex.
    Tricklebank MD; Bristow LJ; Hutson PH; Leeson PD; Rowley M; Saywell K; Singh L; Tattersall FD; Thorn L; Williams BJ
    Br J Pharmacol; 1994 Nov; 113(3):729-36. PubMed ID: 7858861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of striatal glutamate receptors in models of Parkinson's disease.
    Ossowska K; Lorenc-Koci E; Konieczny J; Wolfarth S
    Amino Acids; 1998; 14(1-3):11-5. PubMed ID: 9871435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.